By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – GenMark Diagnostics today reported a net loss of $5.4 million, or $.27 per share in the fourth quarter, compared to a net loss of $3.5 million, or $.30 per share, a year ago.
Registering provides access to this and other free content.
Already have an account?Login Now.
A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.
The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.
In Nature this week: investigation into the genetics of medulloblastoma, and more.
A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.